1. Home
  2. LXFR vs MYGN Comparison

LXFR vs MYGN Comparison

Compare LXFR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$11.60

Market Cap

421.4M

Sector

Industrials

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.66

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LXFR
MYGN
Founded
1898
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.4M
481.6M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
LXFR
MYGN
Price
$11.60
$4.66
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$7.64
AVG Volume (30 Days)
172.7K
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.47%
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$384,600,000.00
$771,400,000.00
Revenue This Year
N/A
$7.19
Revenue Next Year
$5.01
$5.64
P/E Ratio
$41.57
N/A
Revenue Growth
N/A
2.33
52 Week Low
$9.41
$3.76
52 Week High
$16.03
$10.32

Technical Indicators

Market Signals
Indicator
LXFR
MYGN
Relative Strength Index (RSI) 23.84 41.35
Support Level $11.24 $3.93
Resistance Level $12.33 $5.63
Average True Range (ATR) 0.58 0.42
MACD -0.19 0.04
Stochastic Oscillator 3.52 21.43

Price Performance

Historical Comparison
LXFR
MYGN

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: